FastWave Medical this week announced that it has closed its Series Pre-A financing round following its recent acquisition by China Grand Pharmaceutical and Healthcare Holdings.
Minneapolis-based FastWave Medical, incubated by Big Sky Biomedical partners, earmarked the funds to advance research and development and to achieve key regulatory initiatives for its endovascular therapies to treat calcific artery disease.
Get the full story on our sister site, Medical Tubing + Extrusion.